CAMAIONI, Emidio
 Distribuzione geografica
Continente #
NA - Nord America 3.632
EU - Europa 3.164
AS - Asia 1.409
SA - Sud America 308
AF - Africa 29
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 2
Totale 8.551
Nazione #
US - Stati Uniti d'America 3.597
UA - Ucraina 665
IE - Irlanda 613
SG - Singapore 548
IT - Italia 519
HK - Hong Kong 403
RU - Federazione Russa 355
BR - Brasile 278
DE - Germania 263
SE - Svezia 252
FI - Finlandia 191
CN - Cina 130
VN - Vietnam 128
TR - Turchia 80
GB - Regno Unito 73
FR - Francia 48
PL - Polonia 42
CH - Svizzera 24
BE - Belgio 23
KR - Corea 22
NL - Olanda 21
CZ - Repubblica Ceca 20
IN - India 18
AT - Austria 15
CA - Canada 13
BD - Bangladesh 12
GR - Grecia 12
RO - Romania 12
MX - Messico 10
EG - Egitto 9
UZ - Uzbekistan 9
CO - Colombia 8
IL - Israele 7
JP - Giappone 7
LB - Libano 7
MA - Marocco 7
EU - Europa 6
AR - Argentina 5
EC - Ecuador 5
ES - Italia 5
PK - Pakistan 5
ZA - Sudafrica 5
CL - Cile 4
IQ - Iraq 4
SV - El Salvador 4
AM - Armenia 3
ID - Indonesia 3
JM - Giamaica 3
JO - Giordania 3
PH - Filippine 3
VE - Venezuela 3
AZ - Azerbaigian 2
CI - Costa d'Avorio 2
CR - Costa Rica 2
DK - Danimarca 2
LT - Lituania 2
NG - Nigeria 2
NP - Nepal 2
OM - Oman 2
PA - Panama 2
PY - Paraguay 2
SA - Arabia Saudita 2
TM - Turkmenistan 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
DZ - Algeria 1
ET - Etiopia 1
GA - Gabon 1
HN - Honduras 1
HU - Ungheria 1
IR - Iran 1
KW - Kuwait 1
KZ - Kazakistan 1
LU - Lussemburgo 1
LV - Lettonia 1
MD - Moldavia 1
MM - Myanmar 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PE - Perù 1
QA - Qatar 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 8.551
Città #
Dublin 608
Chandler 555
Jacksonville 409
Hong Kong 400
Singapore 346
San Mateo 336
Boardman 214
Perugia 181
Santa Clara 179
Altamura 165
Medford 156
Princeton 154
Dong Ket 119
Moscow 111
Lawrence 105
Wilmington 103
Ann Arbor 97
Munich 87
Andover 86
Izmir 74
Redmond 58
Des Moines 55
Saint Petersburg 49
Beijing 48
Los Angeles 39
Ashburn 34
Helsinki 30
The Dalles 26
Turku 26
Norwalk 23
Seoul 22
Brussels 21
New York 21
San Paolo di Civitate 21
Woodbridge 18
São Paulo 17
Dallas 15
Rome 15
Chicago 14
Bucharest 11
Den Haag 11
Redwood City 11
Rio de Janeiro 11
Auburn Hills 10
Brooklyn 10
Belo Horizonte 9
Milan 9
Shanghai 9
Falls Church 8
Nuremberg 8
Olomouc 8
Brno 7
Cairo 7
Charlotte 7
Krakow 7
London 7
San Diego 7
San Francisco 7
Boston 6
Lausanne 6
Mcallen 6
Ness Ziona 6
Renton 6
Simi Valley 6
Zhengzhou 6
Florence 5
Frankfurt Am Main 5
Ho Chi Minh City 5
Kraków 5
Spoleto 5
Warsaw 5
Bogotá 4
Bologna 4
Brasília 4
Casablanca 4
Centro 4
Denver 4
Detroit 4
Fairfield 4
Gigante 4
Houston 4
Montefalco 4
Montreal 4
Recife 4
Tappahannock 4
Tokyo 4
Winston-Salem 4
Amman 3
Anápolis 3
Campinas 3
Campo Grande 3
Cassino 3
Clarksburg 3
Collazzone 3
Columbus 3
Curitiba 3
Fortaleza 3
Fremont 3
Goiânia 3
Guarulhos 3
Totale 5.376
Nome #
Computational studies in enantioselective liquid chromatography: Forty years of evolution in docking- and molecular dynamics-based simulations 135
Advances in indoleamine 2,3-dioxygenase 1 medicinal chemistry 113
Structure-activity relationships of bisphophonate nucleotide derivatives as P2Y1 receptor antagonists and partial agonists 97
Dexpramipexole blocks Nav1.8 sodium channels and provides analgesia in multiple nociceptive and neuropathic pain models 92
Towards New Neuroprotective Agents: Design and Synthesis of Thieno[2,3-c]-isoquinolinon-5-one as a Potent PARP-1 Inhibitor. 89
Spiro[2.2]pentane as a Dissymmetric Scaffold for Conformationally Constrained Analogues of Glutamic Acid: Focus on Racemic 1-Aminospiro[2.2]pentyl-1,4-dicarboxylic Acids 86
2-Substituted N-ethylcarboxamidoadenosine derivatives as high-affinity agonists at human A3 adenosine receptors 85
3alpha-6alpha-Dihydroxy-7alpha-fluoro-5beta-cholanoate (UPF-680), physicochemical and physiological properties of a new fluorinated bile acid that prevents 17alpha-ethynyl-estradiol-induced cholestasis in rats.. 84
On the way to selective PARP-2 inhibitors. Design, synthesis, and preliminary evaluation of a series of isoquinolinone derivatives. 83
Selective PARP-2 inhibitors increase apoptosis in hippocampal slices but protect cortical cells in models of post-ischaemic brain damage 82
Spiro[2.2]pentane as a dyssymetric scaffold for conformationally constrained analogues of glutamic acid: diastereodivergent synthesis of 1-aminospiro[2.2]pentyl-1,4-dicarboxylic acids 82
PARP inhibitors: polypharmacology versus selective inhibition 82
Novel PARP Inhibitors: Synthesis and Molecular Modeling Studies 81
Metabotropic glutamate receptors: structure and new subtype-selective ligands 81
6a-Ethyl-chenodeoxycholic acid (6-ECDCA), a potent and selective FXR agonist endowed with anticholestatic activity. 80
Binding Mode of 6ECDCA, a Potent Bile Acid Agonist of the Farnesoid X Receptor (FXR) 79
1μs Molecular Dynamics Simulations to study the poisoning effect of the PARP-1 full length enzyme 79
Integrated Fragment-Based Approaches on the Route to Novel IDO1 Modulators 79
Design and synthesis of 4H-thieno[2,3-c]isoquinolin-5-one derivatives as potent PARP-1 inhibitors, on route of new antiischemic agents 77
Molecular recognition in P2 receptors: Ligand development aided by molecular modeling and mutagenesis 76
New Insights from Crystallographic Data: Diversity of Structural Motifs and Molecular Recognition Properties between Groups of IDO1 Structures 76
Critical Assessment of a Structure-Based Screening Campaign for IDO1 Inhibitors: Tips and Pitfalls 76
Adenosine receptor agonists: Synthesis and biological evaluation of the diastereoisomers of 2-(3-hydroxy-3-phenyl-1-propyn-1-yl)NECA 75
Preparation and use of nucleotide bisphosphate as P2Y antagonists 73
2-Alkenyl and 2-alkyl derivatives of adenosine and adenosine-5'-N-ethyluronamide: different affinity and selectivity of E- and Z-diastereomers at A2A adenosine receptors. 73
Rat Brain Guanosine Binding Site:Biological Studies and Pseudo Receptor Construction 72
Adenosine Deaminase: Functional Implications and Different Classes of Inhibitors 72
Adenosine deaminase inhibitors: synthesis and structure-activity relationships of 2-hydroxy-3-nonyl derivatives of azoles. 71
Chromatographic hydrophobicity index: a high-throughput tool to estimate the critical micellar concentration of bile acids 71
Targeting the FXR nuclear receptor through a virtual screening approach 71
N-Decyl-S-trityl-(R)-cysteine, a new chiral selector for "green" ligand-exchange chromatography applications 71
Dexpramipexole improves bioenergetics and outcome in experimental stroke 71
Design, Molecular Modeling Studies, Synthesis and Preliminary Evaluation of Novel PARP-1 Inhibitors on the Road of Antiischemic Agents 70
2-Aralkynyl and 2-heteroalkynyl derivatives of adenosine-5'-N-ethyluronamide as selective A2a adenosine receptor agonists. 69
BF3·Et2O-Promoted Decomposition of Cyclic α-Diazo-β-Hydroxy Ketones: Novel Insights into Mechanistic Aspects 69
Investigating the allosteric reverse signalling of PARP inhibitors with microsecond molecular dynamic simulations and fluorescence anisotropy. 68
Effects of new arylazido compounds of pyridoxal phosphate on ecto-ATPase activity of guinea pig tissues 67
Estimating the hydrophobicity extent of molecular fragments using reversed‐phase liquid chromatography 66
Adenosine deaminase inhibitors: Structure-activity relationships in 1-deazaadenosine and erythro-9-(2-hydroxy-3-nonyl)adenine analogues 66
Derived chromatographic indices as effective tools to study the self-aggregation process of bile acids 65
The relationship between s. Aureus and branched-chain amino acids content in composite cow milk 64
Enantioselective HPLC analysis to assist the chemical exploration of chiral imidazolines 64
Fragment based drug design and diversity-oriented synthesis of carboxylic acid isosteres 64
2-Alkynyl derivatives of adenosine-5'-N-ethyluronamide: selective A2 adenosine receptor agonists with potent inhibitory activity on platelet aggregation. 64
Molecular docking and spatial coarse graining simulations as tools to investigate substrate recognition, enhancer binding and conformational transitions in indoleamine-2,3-dioxygenase (IDO). 63
Adenosine deaminase inhibitors: synthesis, diastereoisomeric resolution and biological activity of 1-(2-hydroxy-3-nonyl)-1,2,4-triazole-3-carboxamide. 63
Discovery and characterization of novel potent PARP-1 inhibitors endowed with neuroprotective properties: From TIQ-A to HYDAMTIQ 63
6α-Ethyl-Chenodeoxycholic Acid (6-ECDCA), a Potent and Selective FXR Agonist Endowed with Anticholestatic Activity 63
Branched-chain amino acids as potential diagnostic and prognostic disease biomarkers 63
Chiral separation of helical chromenes with chloromethyl phenylcarbamate polysaccharide-based stationary phases 62
One Key and Multiple Locks: Substrate Binding in Structures of Tryptophan Dioxygenases and Hydroxylases 62
Modeling of Poly(ADP-ribose)polymerase (PARP) Inhibitors. Docking of Ligands and QSAR 61
Bile acids: property-activity relationship and molecular modelling studies 61
8-Bromo-9-etiladenine come tools per l’ottenimento di antagonisti selettivi per il recettore adenosinico A2B 61
Highlights at the gate of tryptophan catabolism: a review on the mechanism of activation and regulation of indoleamine 2,3-dioxigenase (IDO), a novel target in cancer disease 60
Chiral ligand-exchange separation and resolution ofextremely rigid glutamate analogs: 1-aminospiro[2.2]pentyl-1,4-dicarboxylicacids. 60
Chiral ligand-exchange separation and resolution of extremely rigid glutamate analogues: 1-aminospiro[2.2]pentyl-1,4-dicarboxylic acids 60
The Janus-faced nature of IDO1 in infectious diseases: Challenges and therapeutic opportunities 60
Targeting Wnt-driven cancers: Discovery of novel tankyrase inhibitors 60
Hydrophobic Amino Acid Content in Onions as Potential Fingerprints of Geographical Origin: The Case of Rossa da Inverno sel. Rojo Duro 60
Recent advances in urea- and thiourea-containing compounds: focus on innovative approaches in medicinal chemistry and organic synthesis 60
Investigating the allosteric reverse signalling of PARP inhibitors with microsecond molecular dynamic simulations and fluorescence anisotropy 59
Pharmacology of the highly selective A1 adenosine receptor agonist2-chloro-N6-cyclopentyladenosine. 58
Insights in the PARP1 poisoning effect 58
Synthesis and Biological Evaluation of 2-(3’-(1H-tetrazol-5-yl)bicyclo[1.1.1]pent-1-yl)glycine (S-TBPG), a novel mGlu1 Receptor 57
Rat brain guanosine binding site. Biological studies and pseudo-Receptor construction 57
Synthesis, molecular modelling and preliminary evaluation of a series of new thioidantoine derivatives as inhibitors of indoleamine-2,3-dioxygenase (IDO) 57
Concepts and Molecular Aspects in the Polypharmacology of PARP-1 Inhibitors 57
Synthesis of New Nucleosides by coupling of chloropurines with 2- and 3-deoxy derivatives of N-methyl-D-ribofuranuronamide 56
Molecular determinats for metabotropic glutamate receptor activation and blockade. Molecular dynamics and electrostatic potential analysis studies 56
Identification of the Nicotinamide Salvage Pathway as a New Toxification Route for Antimetabolites 56
Fast chromatographic determination of the bile salt critical micellar concentration 55
Synthesis and biological activity of 3'-deoxy derivative of adenosine (5'-N-methylcarboxamide) (MECA) 55
Compendio teorico-pratico di analisi farmaceutica. Riconoscimento delle sostanze solide iscritte nelle vigenti farmacopee 55
Dual species sphingosine-1-phosphate lyase inhibitors to combine antifungal and anti-inflammatory activities in cystic fibrosis: a feasibility study 54
Inhibitory Effects of 1-Deazaadenosine Analogues on HIV Replication and Adenosine Deaminase 54
Design, Synthesis, Crystallographic Studies and Preliminary Biological Appraisal of New Substituted Triazolo[4,3-b]pyridazin-8-amine Derivatives as Tankyrase Inhibitors. 54
Studies on the interaction between PARP’s catalytic site and inhibitors. Design and synthesis of new class of inhibitor derivatives 53
Dominant Factors Affecting the Chromatographic Behaviour of Bile Acids 52
Heterocycles as Companions on Route to Drug Discovery 52
Bile Acid Derivatives as Ligands of the Farnesoid X Receptor. Synthesis, Evaluation, and Structure Activity Relationship of a Series of Body and Side Chain Modified Analogs of Chenodeoxycholic Acid 52
Stereoselective Synthesis and Preliminary Evaluation of (+)- and (-)-3-methyl-5-carboxy-thien-2-yl-glycine (3-MATIDA): Identification of (+)-3-MATIDA as a Novel mGluR1 Competitive Antagonist 51
Synthesis and Receptor Affinity of Polysubstituted Adenosines 51
Xaa-prolyl dipeptidyl aminopeptidase may play an important role in biofilm formation by Streptococcus mutans 51
Poly(ADP-ribose) catabolism triggers AMP-dependent mitochondrial energy failure 50
Use of RP-HPLC on a Dynamically Coated Artificial Membrane to Predict Intestinal Absorption of Bile Acids 50
Heterocycles as companions on route to drug discovery 49
Studies guanosine binding sites in rat brain: S.A.R. analysis and pharmacophore design 49
HYDAMTIQ: A New, Potent PARP-1 Inhibitor with Neuroprotective Properties 49
Synthesis, enantiomeric separation and preliminary evaluation of a series of new thioidantoine derivatives as inhibitors of indoleamine-2,3-dioxygenase (IDO), a novel target for cancer therapy 49
RP-18-BASE-DEACTIVATED, una nuova fase stazionaria per l’analisi cromatografica degli acidi biliari 49
On the Way to Selective PARP-2 Inhibitors: Design, Synthesis and Preliminary Evaluation of a Series of Isoquinolinone Derivatives 49
Long-lasting neuroprotection and neurological improvement in stroke models with new, potent and brain permeable inhibitors of poly(ADP-ribose) polymerase. 49
The relationships between somatic cells and isoleucine, leucine and tyrosine content in cow milk 49
Combined strategies toward the design and synthesis, of novel inhibitors of indoleamine-2,3-dioxygenase (IDO) 48
High-throughput chromatographic determination of the bile acid critical micellar concentration 48
Towards Selective PARP-2 Inhibitors: Design, Synthesis and Preliminary Evaluation of a Series of Isoquinolinone Derivatives 48
Characterization of potent ligands at human recombinant adenosine receptors 47
Pharmacological inhibition of poly(ADP-ribose) polymerase (PARP) activity in PARP-1 silenced tumour cells increases chemosensitivity to temozolomide and to a N3-adenine selective methylating agent 46
Therapeutic Potential of a Novel Poly(ADP-ribose) Polymerase Inhibitor, Hydamtiq, in Human Pancreatic and Colon Cancers 46
Totale 6.487
Categoria #
all - tutte 43.812
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.812


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.330 3 107 31 100 405 69 121 29 169 32 119 145
2021/20221.214 33 212 11 54 37 11 13 405 43 51 138 206
2022/20232.058 165 391 30 121 178 215 3 83 760 7 76 29
2023/2024851 47 104 44 12 7 15 182 29 88 28 132 163
2024/20252.064 22 202 73 62 252 105 122 93 442 154 319 218
2025/2026132 132 0 0 0 0 0 0 0 0 0 0 0
Totale 8.962